Although the GI symptoms are well been defined in patients with active COVID-19 infection, clinicians evaluating the patient must rule out other common etiologies of GI tract and liver disorders as described below

**GI Tract**

- Non-COVID-19 infectious diarrhea (e.g.;  Difficile)

- Ischemic colitis

- Inflammatory bowel disease (IBD)

- Irritable Bowel Syndrome (IBS)

- Small Bowel Intestinal Overgrowth (SIBO)

- Delayed presentation of acute pancreatitis

- Acute on Chronic Pancreatitis

- Acute Cholecystitis

- Choledocholithiasis

- Peptic Ulcer Disease (PUD)

**Hepatic**

- Acetaminophen toxicity

- Viral Hepatitis (A, B, and C)

- Drug-Induced Liver Injury (DILI)

- Ischemic Hepatitis

- Primary Biliary Cholangitis (PBC)

- Budd-Chiari syndrome

- Sepsis

- Autoimmune Hepatitis

- CMV, EBV or HSV infection

- Muscle related disorders such as polymyositis, rhabdomyolysis